India, March 24 -- Mumbai, India – Wanbury Limited, a leading pharmaceutical company with a significant presence in the global API market and domestic branded formulations, is pleased to announce the launch of two new products this month. The company will introduce C-RED, a branded generic hematinic iron tablet under its formulations division, and Ketamine Hydrochloride under its API (Active Pharmaceutical Ingredient) division.
C-RED: A New Solution for Iron Deficiency
Leveraging its strong equity in the gynecology segment, Wanbury is launching C-RED to address iron deficiency and improve hemoglobin levels, particularly among pregnant women. The new iron supplement contains Liposomal Iron, offering superior absorption, reduced gastri...